113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I

Assessment of red blood cell functional biomarkers following hematopoietic cell transplantation in sickle cell disease patients

Smartphone app for noninvasive at home pediatric hemoglobin monitoring in sickle cell disease

Biophysical characterization of red blood cells in sickle cell trait reveals heterogeneous and intermediate pathophysiological profiles

Innate immune dysregulation in monocytes in sickle cell disease

Pharmacological mechanism of action and therapeutic potential of a quantitative and qualitative RBC and hemoglobin elevating agent AND017 in the Townes SCD model

The role of hepatocyte nuclear factors in the externalization of phosphatidylserine in sickle erythrocytes

Red cell rheology predicts acute chest syndrome and vaso occlusive events in sickle cell disease

Ofirnoflast suppresses heme induced inflammation representing a novel therapeutic strategy for hemolytic anemias

Optimization of stem cell fitness and mobilization using moderate transfusion and an oral anti sickling agent in the sickle mouse model

Single cell analysis reveals distinct γ globin expression profiles in sickle cell disease with pancellular fetal hemoglobin

Resolvins modulate haematopoietic stem and progenitor cell dysfunction and neutrophil activation in sickle cell disease

Targeting hemolysis and raas Osivelotor and losartan ameliorate sickle cell renal pathology

Mitapivat improves red blood cell integrity by reducing membrane ubiquitination accumulation